昨日大跌后今日港股创新药概念股全线反弹。截至发稿康宁杰瑞制药-B涨超14%和黄医药涨超6%、再鼎医药、乐普生物B涨超5%

智通财经09-12

昨日大跌后今日港股创新药概念股全线反弹。截至发稿康宁杰瑞制药-B涨超14%和黄医药涨超6%、再鼎医药、乐普生物B涨超5%加科思-B涨超4%。消息面上多家药企回应称关注到美国方面可能对来自中国的创新药设限的市场传闻但认为相关传闻目前并不影响中国创新药出海的预期。市场人士认为以百济神州、信达生物为代表的龙头Biotech预计在2025年实现盈利拐点后续有望保持高增长态势。伴随产业化能力提升和产品线扩张...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2566442449?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-09-12 11:27","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2566442449","market":"sh","top_or_hot":-1,"title":"昨日大跌后今日港股创新药概念股全线反弹。截至发稿康宁杰瑞制药-B涨超14%和黄医药涨超6%、再鼎医药、乐普生物B涨超5%","media":"智通财经","content":"<div>\n<p>昨日大跌后今日港股创新药概念股全线反弹。截至发稿康宁杰瑞制药-B涨超14%和黄医药涨超6%、再鼎医药、乐普生物B涨超5%加科思-B涨超4%。消息面上多家药企回应称关注到美国方面可能对来自中国的创新药设限的市场传闻但认为相关传闻目前并不影响中国创新药出海的预期。市场人士认为以百济神州、信达生物为代表的龙头Biotech预计在2025年实现盈利拐点后续有望保持高增长态势。伴随产业化能力提升和产品线扩张...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=usstock\">网页链接</a>\n\n</div>\n","source":"live_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昨日大跌后今日港股创新药概念股全线反弹。截至发稿康宁杰瑞制药-B涨超14%和黄医药涨超6%、再鼎医药、乐普生物B涨超5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昨日大跌后今日港股创新药概念股全线反弹。截至发稿康宁杰瑞制药-B涨超14%和黄医药涨超6%、再鼎医药、乐普生物B涨超5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-09-12 11:27 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.zhitongcaijing.com/immediately.html?type=usstock><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>昨日大跌后今日港股创新药概念股全线反弹。截至发稿康宁杰瑞制药-B涨超14%和黄医药涨超6%、再鼎医药、乐普生物B涨超5%加科思-B涨超4%。消息面上多家药企回应称关注到美国方面可能对来自中国的创新药设限的市场传闻但认为相关传闻目前并不影响中国创新药出海的预期。市场人士认为以百济神州、信达生物为代表的龙头Biotech预计在2025年实现盈利拐点后续有望保持高增长态势。伴随产业化能力提升和产品线扩张...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=usstock\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0455707207.USD","symbol_name":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (USD) INC","start_time":0,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","article_id":"2566442449","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2566442449","pubTimestamp":1757647664,"columns":[],"sourceInfo":{"source_id":"live_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"昨日大跌后今日港股创新药概念股全线反弹。截至发稿康宁杰瑞制药-B涨超14%和黄医药涨超6%、再鼎医药、乐普生物B涨超5%加科思-B涨超4%。消息面上多家药企回应称关注到美国方面可能对来自中国的创新药设","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","688235":"百济神州","LU0455707207.USD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (USD) INC","LU1251922891.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) ACC","06160":"百济神州","BK1589":"北水核心资产","BK4614":"Manus概念股","BK4588":"碎股","BK1500":"做空集合股","09688":"再鼎医药","BK4548":"巴美列捷福持仓","06978":"永泰生物-B","LU1303224171.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) INC","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","BK4007":"制药","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU2097828805.USD":"AZ EQUITY CHINA \"A-AZ\" (USD) ACC","BK1588":"回港中概股","BK1191":"制药","BK1161":"生物科技","09966":"康宁杰瑞制药-B","LU1770034418.SGD":"ALL CHINA EQUITY \"A\" (SGDHDG) ACC","00013":"和黄医药","YANG":"三倍做空富时中国ETF-Direxion","LU2097828474.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC A","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","ZLAB":"再鼎医药","02157":"乐普生物-B","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","BK4526":"热门中概股","BK1587":"次新股","ONC":"百济神州","BK4585":"ETF&股票定投概念","LU2097828557.USD":"AZ EQUITY CHINA \"A\" (USD) ACC","BK4139":"生物科技","LU0502904849.HKD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (HKD) ACC","BK1574":"生物医药B类股","01801":"信达生物","LU2097828631.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC","LU1719994722.HKD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (HKD) ACC","HSCEI":"国企指数","01167":"加科思-B","BK1583":"高瓴概念","BK0239":"医药制造","HCM":"和黄医药","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","HSTECH":"恒生科技指数","07226":"南方两倍做多恒科","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD"},"translate_title":"After yesterday's sharp drop, innovative drug concept stocks in Hong Kong stocks rebounded across the board today. As of press time, Corning Jerry Pharmaceuticals-B rose more than 14%, Chi-Med Pharmaceuticals rose more than 6%, Zai Lab, and Lepu Biotech B rose more than 5%","themeId":"25aae963f1d5459eb6e8e1d01007b8cc","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1,"688235":1,"06978":1,"HSCEI":1,"07226":1,"09966":1,"06160":1,"01167":1,"01801":1,"ONC":1,"00013":1,"HSTECH":1,"ZLAB":1,"YANG":1,"02157":1,"HCM":1,"09688":1},"content_text":"昨日大跌后今日港股创新药概念股全线反弹。截至发稿康宁杰瑞制药-B涨超14%和黄医药涨超6%、再鼎医药、乐普生物B涨超5%加科思-B涨超4%。消息面上多家药企回应称关注到美国方面可能对来自中国的创新药设限的市场传闻但认为相关传闻目前并不影响中国创新药出海的预期。市场人士认为以百济神州、信达生物为代表的龙头Biotech预计在2025年实现盈利拐点后续有望保持高增长态势。伴随产业化能力提升和产品线扩张预计未来将有更多Biotech步入盈利周期。（第一财经）。","kind":"live","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2566442449","isCrawlerRequest":true}